Jeffrey Weiss

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Guggenheim Securities LLC is a SEC-registered broker-dealer headquartered in New York City. The firm was founded in 1999 and is a subsidiary of Links Holdings LLC, ultimately held by Guggenheim Partners LLC. Guggenheim Securities’ specializations include the sales and trading of fixed-income securities and sophisticated structured products. The firm offers in-depth analysis and expert execution of trading opportunities to large institutional investors and asset originators. They offer sales and trading services relating to a wide range of instruments.

Auriga USA is a broker/dealer located in New York City. Their research focuses on the semiconductors, information technology and health services sectors.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina.

Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY.

Part of Beach Products, Inc., Pharmaceutical Associates, Inc. is a leading manufacturer and marketer of generic liquid pharmaceuticals. The private company is based in Greenville, SC. The company has been producing better-targeted suspensions, oral solutions, elixirs, syrups, and liquids for almost 50 years. The company offers standard bottle packaging and ready-to-dispense packaging to meet the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Pharmaceutical Associates was the first independent manufacturer to develop vertically integrated unit-dose (ud) packaging and the first to offer complete lines of hard-to-find liquid products in both out-patient and ud packaging. The CEO of the company is Kurt J. Orlofski.

Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ.

Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA.

Par Pharmaceutical Holdings, Inc. operates as a holding company that engages in the development, license, manufacture, market, and distribution of generic drugs. The company was founded on July 12, 2012 and is headquartered in New York.

Endo Pharmaceuticals Solutions, Inc. develops products to treat conditions in urology and endocrinology. The company was founded in 2009 and is headquartered in Malvern, PA.

Cantor Fitzgerald & Co. is the investment bank and brokerage subsidiary of CFS CF & Co. I Holdings LP, which is owned by Cantor Fitzgerald LP in the US. The firm was founded by Bernie Gerald Cantor and John Fitzgerald in 1945. Headquartered in New York City, Cantor Fitzgerald offers clients a global, multi-asset prime brokerage platform with a focus on the quality middle market.